Rainmed Medical Limited (2297.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap313.31M
Enterprise Value323.73M
P/E Ratio-2.78
PEG Ratio-0.05
Price/Sales Ratio8.13
Price/Book Ratio0.53
Enterprise/Revenue15.55
Enterprise/EBITDA-7.27

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-2.85
Operating Margin-2.97
AD

Management Effectiveness

Return On Assets-0.12
Return On Equity-0.19

Income Statement

Revenue19.18M
Revenue/Share0.02
Gross Profit9.04M
EBITDA-67.39M
Net Income-77.08M
Diluted EPS-0.06

Balance Sheet

Total Cash129.01M
Total Cash/Share0.1
Total Debt181.94M
Total Debt/Equity0.55
Current Ratio2.43
Book Value Per Share0.26

Price History

52-Week Change-50.31
52-Week High0.4
52-Week Low0.15
Moving Average 50 Days0.21
Moving Average 200 Days0.25

Statistics

Average Volume178,079
Shares Outstanding1.4B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD